Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

News

Is MI Homes (MHO) Stock Undervalued Right Now?
Is MI Homes (MHO) Stock Undervalued Right Now?

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the

Why Expedia (EXPE) is a Top Value Stock for the Long-Term
Why Expedia (EXPE) is a Top Value Stock for the Long-Term

For new and old investors, taking full advantage of the stock market and investing with confidence are common goals. Zacks Premium provides lots of different ways to do both.

The popular research

Is The TJX Companies (TJX) Stock Outpacing Its Retail-Wholesale Peers This Year?
Is The TJX Companies (TJX) Stock Outpacing Its Retail-Wholesale Peers This Year?

Investors interested in Retail-Wholesale stocks should always be looking to find the best-performing companies in the group. Is TJX (TJX) one of those stocks right now? A quick glance at the

Are Investors Undervaluing Crown Holdings (CCK) Right Now?
Are Investors Undervaluing Crown Holdings (CCK) Right Now?

Here at Zacks, we focus on our proven ranking system, which places an emphasis on earnings estimates and estimate revisions, to find winning stocks. But we also understand that investors develop

Are Investors Undervaluing AllianceBernstein (AB) Right Now?
Are Investors Undervaluing AllianceBernstein (AB) Right Now?

Here at Zacks, we focus on our proven ranking system, which places an emphasis on earnings estimates and estimate revisions, to find winning stocks. But we also understand that investors develop

Has Amylyx Pharmaceuticals (AMLX) Outpaced Other Medical Stocks This Year?
Has Amylyx Pharmaceuticals (AMLX) Outpaced Other Medical Stocks This Year?

For those looking to find strong Medical stocks, it is prudent to search for companies in the group that are outperforming their peers. Is Amylyx Pharmaceuticals, Inc. (AMLX) one of those stocks

Here's Why Gen Digital (GEN) is a Strong Value Stock
Here's Why Gen Digital (GEN) is a Strong Value Stock

Taking full advantage of the stock market and investing with confidence are common goals for new and old investors, and Zacks Premium offers many different ways to do both.

The popular research

Newmont Corporation (NEM) Just Flashed Golden Cross Signal: Do You Buy?
Newmont Corporation (NEM) Just Flashed Golden Cross Signal: Do You Buy?

Newmont Corporation (NEM) reached a significant support level, and could be a good pick for investors from a technical perspective. Recently, NEM broke through the 20-day moving average, which

Las Vegas Sands (LVS) Just Overtook the 20-Day Moving Average
Las Vegas Sands (LVS) Just Overtook the 20-Day Moving Average

Las Vegas Sands (LVS) is looking like an interesting pick from a technical perspective, as the company reached a key level of support. Recently, LVS crossed above the 20-day moving average

Modine (MOD) Just Flashed Golden Cross Signal: Do You Buy?
Modine (MOD) Just Flashed Golden Cross Signal: Do You Buy?

From a technical perspective, Modine (MOD) is looking like an interesting pick, as it just reached a key level of support. MOD recently overtook the 20-day moving average, and this suggests a

Albemarle (ALB) Crossed Above the 20-Day Moving Average: What That Means for Investors
Albemarle (ALB) Crossed Above the 20-Day Moving Average: What That Means for Investors

Albemarle (ALB) is looking like an interesting pick from a technical perspective, as the company reached a key level of support. Recently, ALB crossed above the 20-day moving average, suggesting a

Pure Storage (PSTG) Just Overtook the 20-Day Moving Average
Pure Storage (PSTG) Just Overtook the 20-Day Moving Average

Pure Storage (PSTG) reached a significant support level, and could be a good pick for investors from a technical perspective. Recently, PSTG broke through the 20-day moving average, which suggests a

Booz Allen (BAH) Q2 Earnings: Taking a Look at Key Metrics Versus Estimates
Booz Allen (BAH) Q2 Earnings: Taking a Look at Key Metrics Versus Estimates

Booz Allen Hamilton (BAH) reported $2.89 billion in revenue for the quarter ended September 2025, representing a year-over-year decline of 8.2%. EPS of $1.49 for the same period compares to $1.81 a

Here's What Key Metrics Tell Us About Flagstar Bank (FLG) Q3 Earnings
Here's What Key Metrics Tell Us About Flagstar Bank (FLG) Q3 Earnings

For the quarter ended September 2025, Flagstar Bank (FLG) reported revenue of $519 million, down 16.7% over the same period last year. EPS came in at -$0.07, compared to -$0.69 in the year-ago

Wall Street Analysts Think Axon (AXON) Is a Good Investment: Is It?
Wall Street Analysts Think Axon (AXON) Is a Good Investment: Is It?

The recommendations of Wall Street analysts are often relied on by investors when deciding whether to buy, sell, or hold a stock. Media reports about these brokerage-firm-employed (or sell-side)

Compared to Estimates, HCA (HCA) Q3 Earnings: A Look at Key Metrics
Compared to Estimates, HCA (HCA) Q3 Earnings: A Look at Key Metrics

For the quarter ended September 2025, HCA Healthcare (HCA) reported revenue of $19.16 billion, up 9.6% over the same period last year. EPS came in at $6.96, compared to $5.05 in the year-ago

Wall Street Analysts Think AbbVie (ABBV) Is a Good Investment: Is It?
Wall Street Analysts Think AbbVie (ABBV) Is a Good Investment: Is It?

The recommendations of Wall Street analysts are often relied on by investors when deciding whether to buy, sell, or hold a stock. Media reports about these brokerage-firm-employed (or sell-side)

Compared to Estimates, Illinois Tool Works (ITW) Q3 Earnings: A Look at Key Metrics
Compared to Estimates, Illinois Tool Works (ITW) Q3 Earnings: A Look at Key Metrics

For the quarter ended September 2025, Illinois Tool Works (ITW) reported revenue of $4.06 billion, up 2.3% over the same period last year. EPS came in at $2.81, compared to $2.65 in the year-ago

Lam Research (LRCX) Is Considered a Good Investment by Brokers: Is That True?
Lam Research (LRCX) Is Considered a Good Investment by Brokers: Is That True?

Investors often turn to recommendations made by Wall Street analysts before making a Buy, Sell, or Hold decision about a stock. While media reports about rating changes by these brokerage-firm

Brokers Suggest Investing in SharkNinja, Inc. (SN): Read This Before Placing a Bet
Brokers Suggest Investing in SharkNinja, Inc. (SN): Read This Before Placing a Bet

When deciding whether to buy, sell, or hold a stock, investors often rely on analyst recommendations. Media reports about rating changes by these brokerage-firm-employed (or sell-side) analysts

Virtus (VRTS) Q3 Earnings: Taking a Look at Key Metrics Versus Estimates
Virtus (VRTS) Q3 Earnings: Taking a Look at Key Metrics Versus Estimates

Virtus Investment Partners (VRTS) reported $196.69 million in revenue for the quarter ended September 2025, representing a year-over-year decline of 4.1%. EPS of $6.69 for the same period compares

Stellar Bancorp (STEL) Q3 Earnings: How Key Metrics Compare to Wall Street Estimates
Stellar Bancorp (STEL) Q3 Earnings: How Key Metrics Compare to Wall Street Estimates

Stellar Bancorp (STEL) reported $105.63 million in revenue for the quarter ended September 2025, representing a year-over-year decline of 2%. EPS of $0.50 for the same period compares to $0.63 a

General Dynamics (GD) Q3 Earnings: Taking a Look at Key Metrics Versus Estimates
General Dynamics (GD) Q3 Earnings: Taking a Look at Key Metrics Versus Estimates

General Dynamics (GD) reported $12.91 billion in revenue for the quarter ended September 2025, representing a year-over-year increase of 10.6%. EPS of $3.88 for the same period compares to $3.35 a

P&G (PG) Q1 Earnings: Taking a Look at Key Metrics Versus Estimates
P&G (PG) Q1 Earnings: Taking a Look at Key Metrics Versus Estimates

Procter & Gamble (PG) reported $22.39 billion in revenue for the quarter ended September 2025, representing a year-over-year increase of 3%. EPS of $1.99 for the same period compares to $1.93 a year

Wall Street Analysts See Blue Bird (BLBD) as a Buy: Should You Invest?
Wall Street Analysts See Blue Bird (BLBD) as a Buy: Should You Invest?

When deciding whether to buy, sell, or hold a stock, investors often rely on analyst recommendations. Media reports about rating changes by these brokerage-firm-employed (or sell-side) analysts